The increasing trend of highly potent active pharmaceutical ingredients (HPAPIs) being used in new drug development candidates has created a tremendous demand for high containment development and production capabilities. Learn more about Alcami's HPAPI capabilities.
Alcami will support your animal health products with precise attention to quality by design and process development. We have experience with over 50 animal health products ranging from concept through commercialization in API manufacturing, oral solid dose, and sterile (liquid and lyophilized) products.
Work with Alcami to accelerate your drug product through the clinic to commercial launch.
Whether you are looking for an all-inclusive integrated offering or an individualized development or manufacturing service, Alcami has the solution to the complex needs of your product.
THOUGHT LEADERSHIP
White Paper: Optimizing HPAPI Manufacturing Performance
Orphan Drug Case Study: Abeona Therapeutics
White Paper: Insight into Orphan Drug Formulations and Regulations
Alcami Introduces Rapid Sterility
500Investigational New Drug (IND) Filings
400,000+ft² across our facilities
600 US & EU regulatory filings
COMPANY NEWS
Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
UPCOMING EVENTS
CPhI Japan – 3 / 16 - 3 / 18
CED Life Science – 3 / 17 - 3 / 19
DCAT Week – 3 / 23 - 3 / 26
World Orphan Drug Congress – 4 / 29 - 5 / 1
